Company Profiles

driven by the PitchBook Platform

Valeritas

Description

Developer of innovative technologies designed to improve the health and quality of life for people with Type 2 diabetes. The company's technologies flagship product, V-Go Disposable Insulin Delivery device is an easy-to-use wearable insulin device that is adhered to the skin every 24 hours, enabling patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections.

2006

Founded

PUBLIC

Status

51-200

Employees

2PO

Latest Deal Type

$50M

Latest Deal Amount

$460M

Total Amount Raised

Description

Developer of innovative technologies designed to improve the health and quality of life for people with Type 2 diabetes. The company's technologies flagship product, V-Go Disposable Insulin Delivery device is an easy-to-use wearable insulin device that is adhered to the skin every 24 hours, enabling patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections.

Website:

www.valeritas.com

Ownership Status

Publicly held

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery
Medical Supplies

Primary Office

750 Route 202 South Suite 600 Bridgewater, NJ 08807United States +1 (908) 927-9920
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Valeritas's full profile, request a free trial.

Valeritas Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Valeritas Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Valeritas Investors (18)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Abingworth ManagementVenture CapitalMinority000 0000000 0000
Advanced Technology VenturesVenture CapitalMajority000 0000000 0000
Agate Medical InvestmentsVenture CapitalMinority000 0000000 0000
BioValve TechnologiesCorporationMinority000 0000000 0000
CHL Medical PartnersVenture CapitalMinority000 0000000 0000
Abingworth Management Venture Capital
Advanced Technology Ventures Venture Capital
Agate Medical Investments Venture Capital
BioValve Technologies Corporation
CHL Medical Partners Venture Capital

Valeritas Executive Team (13)

NameTitleBoard
Seat
Contact
Info
John TimberlakeBoard Member, Chief Executive Officer and President
Erick LuceraExecutive Vice President & Chief Financial Officer
Matthew NguyenChief Commercial Officer
Geoffrey JenkinsExecutive Vice President, Manufacturing, Operations and Research & Development
Darcy TomsVice President, Business Development
John Timberlake Board Member, Chief Executive Officer and President
Erick Lucera Executive Vice President & Chief Financial Officer
Matthew Nguyen Chief Commercial Officer
Geoffrey Jenkins Executive Vice President, Manufacturing, Operations and Research & Development
Darcy Toms Vice President, Business Development

Valeritas Board Members (13)

NameRepresentingRoleSinceContact
Info
Daniel PelakWelsh, Carson, Anderson & StoweOperating Partner - Consultant000 0000
David SchulteKaiser Permanente VenturesVice President & Senior Managing Director000 0000
Elizabeth RockettKaiser Permanente VenturesDirector000 0000
Ittai HarelPitango Venture CapitalManaging General Partner000 0000
John RyanONSET VenturesPartner, Medical Technology000 0000
Daniel Pelak Operating Partner - Consultant Welsh, Carson, Anderson & Stowe
David Schulte Vice President & Senior Managing Director Kaiser Permanente Ventures
Elizabeth Rockett Director Kaiser Permanente Ventures
Ittai Harel Managing General Partner Pitango Venture Capital
John Ryan Partner, Medical Technology ONSET Ventures
Request full access to PitchBook